Trevi Therapeutics, Inc. (TRVI)

CIK 1563880 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Trevi Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 6, 202610-Q0001193125-26-338023
Aug 6, 20268-K0001193125-26-337974
Aug 6, 2026SCHEDULE 13G/A0000315066-26-002184
Aug 6, 2026S-80001193125-26-338071
Jun 4, 202640001193125-26-257366
Jun 4, 20268-K0001193125-26-257365
Jun 4, 202640001193125-26-257370
Jun 4, 202640001193125-26-257371
Jun 4, 202640001193125-26-257488
Jun 4, 202640001193125-26-257373
May 7, 2026SCHEDULE 13D/A0001072613-26-000382
May 6, 2026SCHEDULE 13G/A0000315066-26-001314
May 5, 20268-K0001193125-26-206382
May 5, 202610-Q0001193125-26-206390
Apr 21, 2026DEF 14A0001193125-26-166695
Apr 21, 2026DEFA14A0001193125-26-166693
Apr 21, 2026ARS0001193125-26-166694
Apr 17, 2026424B50001193125-26-161582
Apr 17, 20268-K0001193125-26-160355
Apr 16, 2026424B50001193125-26-159041
Apr 10, 2026PRE 14A0001193125-26-151354
Mar 27, 2026SCHEDULE 13G/A0000102909-26-002401
Mar 17, 202610-K0001193125-26-110783
Mar 17, 20268-K0001193125-26-110767
Mar 9, 20268-K0001193125-26-098676